C.H. Robinson sees revenues and profits decline in Q3

Our legacy articles (one week old or more) require membership to view. Membership is completely free!

Click to register. or Click to login


GSK Board and Committee changes

Our legacy articles (one week old or more) require membership to view. Membership is completely free!

Click to register. or Click to login


GSK Executive Director change

Our legacy articles (one week old or more) require membership to view. Membership is completely free!

Click to register. or Click to login


GSK announces significant new investment in UK manufacturing network

Our legacy articles (one week old or more) require membership to view. Membership is completely free!

Click to register. or Click to login


GSK delivers further progress against strategy with strong Q2 performance

Our legacy articles (one week old or more) require membership to view. Membership is completely free!

Click to register. or Click to login


GSK divests non-core assets to Aspen

Our legacy articles (one week old or more) require membership to view. Membership is completely free!

Click to register. or Click to login


GSK sets out further steps to address emerging global health security challenges

Our legacy articles (one week old or more) require membership to view. Membership is completely free!

Click to register. or Click to login


Emma Walmsley to succeed Andrew Witty as Chief Executive Officer of GlaxoSmithKline

Our legacy articles (one week old or more) require membership to view. Membership is completely free!

Click to register. or Click to login


GlaxoSmithKline announces intention to sell remaining holding in Aspen

Our legacy articles (one week old or more) require membership to view. Membership is completely free!

Click to register. or Click to login


GlaxoSmithKline completes sale of remaining Aspen shares

Our legacy articles (one week old or more) require membership to view. Membership is completely free!

Click to register. or Click to login

<< < > >>